Intervention Protocol

Chemotherapy with Camptothecin compounds for metastatic colorectal cancer

  1. Donghao Lv2,
  2. Huan Song2,
  3. Fan He2,
  4. Beibei Cui3,
  5. Yalun Li3,
  6. Taixiang Wu1,*

Editorial Group: Cochrane Colorectal Cancer Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 8 OCT 2008

DOI: 10.1002/14651858.CD007521

Database Title

Additional Information

How to Cite

Lv D, Song H, He F, Cui B, Li Y, Wu T. Chemotherapy with Camptothecin compounds for metastatic colorectal cancer (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD007521. DOI: 10.1002/14651858.CD007521.

Author Information

  1. 1

    West China Hospital, Sichuan University, Chinese Cochrane Centre, Chinese EBM Centre, INCLEN CERTC in West China Hospital, Chengdu, Sichuan, China

  2. 2

    Sichuan University, Chengdu, China, West China Hospital, Chengdu, Sichuan, China

  3. 3

    Sichuan University, West China Hospital, Chengdu, Sichuan, China

*Taixiang Wu, Chinese Cochrane Centre, Chinese EBM Centre, INCLEN CERTC in West China Hospital, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China. txwutx@hotmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Full (123K)
 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

1. To assess the effectiveness of adding one camptothecin compounds to other chemotherapy agents in the first line and second line treatment of metastatic colorectal cancer.
2. To assess the effectiveness of individual camptothecin compounds compared with each other (e.g. irinotecan, topotecan and homocamptothecin).
3. To assess the effectiveness of different formulations, dose, route of administration and schedule of the same type of camptothecin compounds.

View Full Article (HTML) Full (123K)